#investing / Page 3

New data reveals TNX-801 vaccine's exceptional efficacy against mpox and smallpox with single dose, proving safe for immunocompromised patients. See trial results.

Former AvenCell CFO brings $1B+ fundraising expertise to accelerate BioCryst's rare disease pipeline and ORLADEYO growth. Learn strategic expansion plans.

New BTK degrader gains momentum with EMA orphan status for Waldenström macroglobulinemia treatment. Latest regulatory win adds to FDA Fast Track designation. See development details.

Freightos integrates air and ground booking platform across SEKO's 60-country network. New partnership accelerates quote speeds and reduces operational costs. Learn more.

Strategic appointments from Roche and FDA bolster QuidelOrtho's quality and regulatory capabilities. New SVPs bring 20+ years of diagnostics expertise. Learn more.

Join CCSI's leadership team for Q2 2025 results presentation with live Q&A session. CEO Scott Turicchi and executives share latest financial insights. Register now.

Former Morgan Stanley director and NIO executive join NWTN's leadership team, accelerating its evolution from EV maker to global smart technology platform. See strategic details.

Talisker launches processing operations at Nicola's Craigmont Mill while advancing development across multiple mining levels. See production timeline and stope details.

Strategic $5M private placement enables 100% ownership of Hope Brook Gold Project. Backed by Michael Gentile, PowerOne Group in tier-one jurisdiction. See expansion plans.

Clough Global Opportunities Fund declares consistent $0.0501 monthly distributions for July-September 2025. Fund manages $385.2M in assets. See payment schedule.